rebel Financial rebel Financial
← All Posts
COGT

Cogent Biosciences, Inc.

June 10, 2026 • Author: Phil Ratcliff • COGT
Item Proposal Vote
1 Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified.
1.01 Dr. Chris Cain ✓ For
1.02 Arlene M. Morris ✓ For
1.03 Todd Shegog ✓ For
2 Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. ✓ For
3 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. ✓ For
Attachments
📄
COGT_ANNUAL_REPORT_2025.pdf 3.2 MB
📄
COGT_PROXY_STATEMENT.pdf 0.5 MB
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.